tetano
Editor, Senior Moderator
Influenza Other Respir Viruses. 2014 Nov 15. doi: 10.1111/irv.12293. [Epub ahead of print]
Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management.
Hurt AC1, Hui DS, Hay A, Hayden FG.
Author information
Abstract
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
? 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
KEYWORDS:
Antivirals; clinical management; immunocompromised; influenza; respiratory; treatment
PMID:
25399715
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25399715
Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management.
Hurt AC1, Hui DS, Hay A, Hayden FG.
Author information
Abstract
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
? 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
KEYWORDS:
Antivirals; clinical management; immunocompromised; influenza; respiratory; treatment
PMID:
25399715
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25399715